Lyme Disease: Call for a "Manhattan Project" to Combat the Epidemic

PLoS Pathogens

Volumn 10, Issue 1, 2014, Pages

  Stricker, Raphael B ^a   Johnson, Lorraine ^a  

^a International Lyme and Associated Diseases Society   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; LYME DISEASE; MEDICAL RESEARCH; METABOLISM; ORGANIZATION AND MANAGEMENT; PROCEDURES; PUBLIC HEALTH SERVICE; TRENDS; UNITED STATES;

BIOMEDICAL RESEARCH; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); HUMANS; LYME DISEASE; UNITED STATES;

EID: 84893742667     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003796     Document Type: Article

References (36)

1. Harvey WT, Salvato P, (2003) 'Lyme disease': ancient engine of an unrecognized borreliosis pandemic? Med Hypotheses 60: 742-759.
2. Johnson L, Stricker RB, (2004) Treatment of Lyme disease: a medicolegal assessment. Expert Rev Anti Infect Ther 2: 533-557.
3. Stricker RB, Johnson L, (2011) Lyme disease: The next decade. Infect Drug Resist 4: 1-9.
4. Stricker RB, Johnson L, (2010) Lyme disease diagnosis and treatment: Lessons from the AIDS epidemic. Minerva Med 101: 419-425.
5. Steere AC, Taylor E, McHugh GL, Logigian EL, (1993) The overdiagnosis of Lyme disease. JAMA 269: 1812-1816.
6. Dressler F, Whalen JA, Reinhardt BN, Steere AC, (1993) Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 167: 392-400.
7. Wormser GP, Dattwyler RJ, Shapiro ED, et al. (2006) The clinical assessment, treatment, and prevention of Lyme disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 41: 1089-1134.
8. Feder HM Jr, Johnson BJ, O'Connell S, Shapiro ED, Steere AC, Wormser GP, (2007) Ad Hoc International Lyme Disease Group, A critical appraisal of 'chronic Lyme disease'. N Engl J Med 357: 1422-30.
9. Johnson L, Aylward A, Stricker RB, (2011) Healthcare access and burden of care for patients with Lyme disease: a large United States survey. Health Policy 102: 64-71.
10. Stricker RB, Johnson L, (2011) The pain of chronic Lyme disease: moving the discourse backward? FASEB J 25: 4085-7.
11. Burrascano JJ, (1993) The overdiagnosis of Lyme disease. JAMA 270: 2682.
12. Cameron D, Gaito A, Harris N, et al. (2004) Evidence-based guidelines for the management of Lyme disease. Expert Rev Anti-Infect Ther 2 (1 Suppl):: S1-13.
13. Stricker RB, Lautin A, (2003) The Lyme Wars: time to listen. Expert Opin Investig Drugs 12: 1609-1614.
14. Kullberg BJ, Berende A, van der Meer JW, (2011) The challenge of Lyme disease: tired of the Lyme wars. Neth J Med 69: 98-100.
15. Hinckley A, Connally N, Meek J, Johnson BJ, Kemperman M, et al. (2013) TickNET: A survey of testing practices for Lyme disease by large commercial laboratories -United States, 2008. Presented at the 13th International Conference on Lyme Borreliosis and other Tick-Borne Diseases, Boston, MA, August 19, 2013. Available: http://www.poughkeepsiejournal.com/assets/pdf/BK211782914.pdf.
16. Hook S, Nelson C, Mead P (2013) Self-reported Lyme disease diagnosis, treatment, and recovery: Results from 2009, 2011, & 2012 HealthStyles nationwide surveys. Presented at the 13th International Conference on Lyme Borreliosis and other Tick-Borne Diseases, Boston, MA, August 19, 2013. Available: http://www.poughkeepsiejournal.com/assets/pdf/BK211780914.pdf.
17. Nelson C, Saha S, Shankar M, Kugeler K, Hinckley A, et al. (2013) Epidemiology and clinical characteristics of Lyme disease diagnosed by health care providers: Results from a large national database study. Presented at the 13th International Conference on Lyme Borreliosis and other Tick-Borne Diseases, Boston, MA, August 19, 2013. Available: http://www.poughkeepsiejournal.com/assets/pdf/BK211781914.pdf.
18. Cairns V, Godwin J, (2005) Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Int J Epidemiol 34: 1340-1345.
19. Phillips SE, Burrascano JJ, Horowitz R, Savely VR, Stricker RB, (2006) Lyme disease testing. Lancet Infect Dis 6: 122.
20. Stricker RB, (2007) Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with Lyme disease. Clin Infect Dis 45: 149-57.
21. Berndtson K, (2013) Review of evidence for immune evasion and persistent infection in Lyme disease. Int J Gen Med 6: 291-306.
22. Stricker RB, Johnson L, (2013) Persistent infection in chronic Lyme disease: does form matter? Res J Infect Dis 1: 2.
23. Miklossy J, (2012) Chronic or late Lyme neuroborreliosis: analysis of evidence compared to chronic or late neurosyphilis. Open Neurol J 6: 146-157.
24. Ljøstad U, Mygland Å, (2013) Chronic Lyme; diagnostic and therapeutic challenges. Acta Neurol Scand Suppl 196: 38-47.
25. Liegner K (2012) Valley views: Major initiative needed to fight tick-borne infections. Poughkeepsie Journal, August 21, 2012. Available: http://www.poughkeepsiejournal.com/article/20120822/OPINION04/308220005/Valley-Views-Major-initiative-needed-fight-tick-borne-infections.
26. Viswanathan M, Carey TS, Belinson SE, et al. (2013) Identifying and managing nonfinancial conflicts of interest for systematic reviews. Methods Research Report. AHRQ Publication No. 13-EHC085-EF. Rockville, MD: Agency for Healthcare Research and Quality; May 2013. Available: www.effectivehealthcare.ahrq.gov/reports/final.cfm.
27. Johnson L, Stricker RB, (2010) The Infectious Diseases Society of America Lyme guidelines: a cautionary tale about development of clinical practice guidelines. Philos Ethics Humanit Med 5: 9.
28. Johnson L, Stricker RB, (2010) Final report of the Lyme Disease Review Panel of the Infectious Diseases Society of America: A Pyrrhic victory? Clin Infect Dis 51: 1108-1109.
29. Sapi E, Kaur N, Anyanwu S, Luecke DF, Datar A, et al. (2011) Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi. Infect Drug Resist 4: 97-113.
30. Sapi E, Pabbati N, Datar A, Davies EM, Rattelle A, et al. (2013) Improved culture conditions or the growth and detection of Borrelia from human serum. Int J Med Sci 10: 362-376.
31. Nolte O, (2012) Nucleic acid amplification based diagnostic of Lyme (neuro-)borreliosis- Lost in the jungle of methods, targets, and assays? Open Neurol J 6: 129-139.
32. Stricker RB, Delong AK, Green CL, Savely VR, Chamallas SN, et al. (2011) Benefit of intravenous antibiotic therapy in patients referred for treatment of neurologic Lyme disease. Int J Gen Med 4: 639-646.
33. Donta ST, (2012) Issues in the diagnosis and treatment of Lyme disease. Open Neurol J 6: 140-145.
34. Stricker RB, (2008) Lymerix® risks revisited. Microbe 3: 1-2.
35. Marks DH, (2011) Neurological complications of vaccination with outer surface protein A (OspA). Int J Risk Saf Med 23: 89-96.
36. Cohen J, (2013) AIDS research. More woes for struggling HIV vaccine field. Science 340: 667.